This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
MARS1 / Methionine--tRNA ligase, cytoplasmic · IHC design guide
Design Immunohistochemistry for MARS1
Plan chromogenic IHC of paraffin sections using the catalog antibody’s documented conditions (datasheet A00216-1). Assess the general cytoplasmic tissue pattern (HPA tissue IHC), allowing for proliferation-dependent nucleolar localization (UniProt).
Evidence assembled Oct 2026 · For research use; verify linked source records and product datasheet before use
MARS1 Immunohistochemistry Experimental Design Guide
Expected localisation, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
Must know before staining
| Expected localisation | General cytoplasmic staining (HPA tissue IHC) | |
| Staining pattern | Cytoplasmic staining in glandular cells (HPA tissue IHC) | |
| Antigen retrieval | EDTA pH 8.0 HIER, heat-mediated (datasheet A00216-1) | |
| Positive control | Breast+4 more · see all | |
| Negative control | None in HPA (detected in all 45 tissues); use no-primary + isotype controls |
Important caveats
Reasons your staining may differ from the expected pattern.
| Fixation | Keep paraffin-section fixation consistent. (standard IHC practice; not target-specific) | |
| Caveat | Nucleolar signal can disappear in quiescent cells (UniProt) | |
| Regulation | Nucleolar localization in proliferative cells (UniProt) | |
| Isoform / epitope | 2 isoforms; epitope impact unknown; no TM segment (UniProt) |
Section 1
Recommended MARS1 IHC & IF Protocols
Compare the catalog antibody’s IHC-P protocol (datasheet A00216-1) with four published MARS1 IHC protocols (PMC12293401; PMC10670752; PMC12676747; PMC12624232).
| Sample | Paraffin-embedded human prostate cancer tissue; fixative not specified (datasheet A00216-1) |
| Fixation | Image fixative and duration unreported (datasheet A00216-1); verify before use. |
| Sectioning | 4–5 µm sections on charged slides (standard) |
| Deparaffinisation | Xylene, graded ethanol series to water (standard) |
| Antigen retrieval | Heat retrieval: EDTA pH 8.0 (datasheet A00216-1); 20 min, 95–100 °C (standard) |
| Peroxidase block | 3% H2O2, 10 min, room temperature (standard) |
| Blocking | 10% goat serum (datasheet A00216-1) |
| Primary antibody | Rabbit anti-MARS1, 2-5 μg/ml (datasheet A00216-1) |
| Primary incubation | Overnight at 4 °C (datasheet A00216-1) |
| Detection | HRP-conjugated secondary, DAB chromogen (datasheet A00216-1) |
| Counterstain | Hematoxylin, blue, dehydrate and mount (standard) |
| Expected result | MARS1-positive staining in glandular cells of breast (HPA tissue IHC: High). HPA tissue profile: General cytoplasmic expression. No signal in the no-primary control. |
💡Decision noteStart with EDTA pH 8.0 heat retrieval (datasheet A00216-1); citrate retrieval at 100 °C for 10 min is a published alternative (PMC12293401).
Section 2
What Is the Expected MARS1 Staining Pattern?
MARS1 should show mainly cytoplasmic staining in paraffin sections, including glandular, respiratory epithelial and neuronal cells reported as high by HPA (HPA: tissue IHC). Cytosolic localization is consistent with a protein lacking a transmembrane segment (UniProt P56192: localization and topology). HPA rates the tissue staining pattern Supported, with medium consistency between staining and RNA expression (HPA: tissue IHC reliability).
| Cytoplasmic staining in breast or colon glandular cells, or bronchial respiratory epithelial cells. | This fits HPA’s general cytoplasmic pattern and its High staining calls for those cells (HPA: tissue IHC). Compare signal with adjacent tissue structures; a positive call should identify stained cells and their compartment. |
| Nucleolar staining in some cells alongside cytoplasmic staining. | This can fit MARS1 in proliferative cells: UniProt reports nucleolar localization there and disappearance from the nucleolus in quiescent cells (UniProt P56192: subcellular location). Nucleolar staining alone needs careful review against the expected cytoplasmic pattern (HPA: tissue IHC). |
| Predominantly membranous or extracellular staining, with little cytoplasmic signal. | That is discordant with the reported cytoplasmic pattern and lack of a transmembrane segment (HPA: tissue IHC; UniProt P56192: topology). Check morphology and controls before interpreting it as MARS1; the pattern alone cannot identify the artefact. |
| Strong chondrocyte staining, especially if it resembles the signal in high-staining glandular cells. | HPA lists chondrocytes as Low, so unexpectedly strong staining warrants a check for cross-reactivity or detection background (HPA: tissue IHC; general IHC practice). Low is an observed level, not a verified negative control. |
| Diffuse stain across cells, matrix or the whole section, or no signal in a known high-staining cell population. | Diffuse stain obscures the reported cytoplasmic pattern; absent signal in HPA High cells fails to reproduce that reference observation (HPA: tissue IHC). Neither finding alone distinguishes a technical problem from a specimen difference. |
💡Expected MARS1 appearanceCall a section positive when identifiable glandular, respiratory epithelial or neuronal cells show appreciable cytoplasmic staining consistent with HPA High calls; broad, structure-independent stain or dominant membrane staining is suspect (HPA: tissue IHC; UniProt P56192: topology).
| Tissue and cell selection | HPA reports High staining in breast, colon, duodenum, endometrium and epididymis glandular cells, bronchial respiratory epithelium, cortical neurons and cerebellar synaptic glomeruli cores (HPA: tissue IHC). Choose a reference with recognizable anatomy; HPA lists no negative tissue. |
| Subcellular location and cell state | Cytosol is the principal location (UniProt P56192: subcellular location; HPA: subcellular ICC-IF). Nucleolar localization depends on proliferation and is reported to disappear in quiescent cells (UniProt P56192: subcellular location); its absence does not negate cytoplasmic staining. |
| Antibody evidence | Both listed antibodies have Supported IHC status; HPA004125 has Enhanced ICC status, while CAB017097 has Supported ICC status (HPA: antibody validation). These application ratings do not demonstrate identical staining in every tissue or establish a fixation effect. |
| Isoforms and epitope coverage | UniProt lists two MARS1 isoforms (UniProt P56192: isoforms). The supplied records give no antibody epitope or isoform coverage, so an isoform-specific staining difference cannot be assigned from this evidence. |
| IF/ICC Q: What localization should be expected? | A: Mainly cytosolic signal; HPA additionally reports sperm mid piece, principal piece and end piece localization (HPA: subcellular ICC-IF). These are IF observations, while this page’s primary readout is chromogenic IHC on paraffin sections. |
| Fixation sensitivity | Target-specific fixation sensitivity is unreported in the supplied UniProt and HPA records. Interpret changes across specimen preparations with matched controls (general IHC practice); do not attribute a change specifically to MARS1 epitope masking. |
| Situation | Likely cause | Next action |
|---|---|---|
| No stain in a reference section expected to contain high-staining glandular or respiratory epithelial cells. | The result does not reproduce HPA’s High calls; the cause is unresolved by those observations (HPA: tissue IHC). | Confirm the expected cells are present, then review antigen retrieval, antibody dilution and detection controls as general IHC workflow checks (general IHC practice). |
| Stain appears mainly on cell borders or in extracellular material. | The distribution conflicts with cytoplasmic MARS1 and its lack of a transmembrane segment (HPA: tissue IHC; UniProt P56192: topology). | Review cellular boundaries and compare with a known cytoplasmic reference pattern; check a no-primary control for detection background (general IHC practice). |
| Nucleolar signal is absent although cytoplasmic signal is clear. | UniProt reports nucleolar localization in proliferative cells and its disappearance in quiescent cells (UniProt P56192: subcellular location). | Score the cytoplasmic pattern separately; assess cell state before treating missing nucleolar signal as a failed stain (UniProt P56192: subcellular location). |
| Strong signal appears in chondrocytes. | This exceeds HPA’s Low call and could reflect cross-reactivity or detection background; the record cannot distinguish them (HPA: tissue IHC; general IHC practice). | Compare intensity and compartment with a high-staining reference, and inspect a no-primary control (HPA: tissue IHC; general IHC practice). |
| Brown chromogen covers tissue broadly and obscures cell boundaries. | Diffuse background prevents assessment of HPA’s general cytoplasmic pattern (HPA: tissue IHC). Endogenous enzyme activity is one possible cause with enzyme-based detection (general IHC practice). | Check a no-primary control and the detection-only background; review blocking, washes and endogenous enzyme blocking appropriate to the detection system (general IHC practice). |
| Two IHC antibodies give different staining patterns. | Both have Supported IHC status, but that rating does not establish agreement in this specimen; epitope and isoform coverage are unspecified (HPA: antibody validation; UniProt P56192: isoforms). | Compare the same cell types and compartments on matched sections, then retain the interpretation supported by tissue morphology and controls (general IHC practice). |
Experiment evidence
IHC & IF images showing MARS1 staining
A00216-1 · IHCIHC analysis of MARS1 using anti-MARS1 antibody (A00216-1). MARS1 was detected in a paraffin-embedded section of human prostate cancer tissu
A00216-1 · IHCIHC analysis of MARS1 using anti-MARS1 antibody (A00216-1). MARS1 was detected in a paraffin-embedded section of human thyroid cancer tissue
A00216-1 · IFIF analysis of MARS1 using anti-MARS1 antibody (A00216-1). MARS1 was detected in an immunocytochemical section of U2OS cells. Enzyme antigen
HPA · Cerebral cortexHuman Protein Atlas IHC, Cerebral cortex. Source: https://www.proteinatlas.org/ENSG00000166986-MARS1/tissue/cerebral+cortex#imid_4396528
HPA · ColonHuman Protein Atlas IHC, Colon. Source: https://www.proteinatlas.org/ENSG00000166986-MARS1/tissue/colon#imid_4396454
HPA · LiverHuman Protein Atlas IHC, Liver. Source: https://www.proteinatlas.org/ENSG00000166986-MARS1/tissue/liver#imid_4396447
HPA · PancreasHuman Protein Atlas IHC, Pancreas. Source: https://www.proteinatlas.org/ENSG00000166986-MARS1/tissue/pancreas#imid_4396406
HPA · ICC-IF A-431Human Protein Atlas immunofluorescence, A-431, antibody CAB017097; green = MARS1, blue = nucleus, red = microtubules.
HPA · ICC-IF A-431Human Protein Atlas immunofluorescence, A-431, antibody CAB017097; green = MARS1, blue = nucleus, red = microtubules.
← swipe / scroll for more images →
Real IHC / IF data behind the staining-pattern expectations in this section.
Sample controls for MARS1 IHC & IF
🧪Start with breast: its glandular cells should stain strongly (HPA: High in breast glandular cells). HPA lists no negative tissue and detects MARS1 in all 45 scored tissues, so no-primary and isotype controls carry the negative; any validated negative cells within the breast section should lack specific cytoplasmic DAB staining, but the supplied HPA row identifies no such cell type (HPA: no negative rows; UniProt P56192: cytosolic localization).
Positive control tissue: Breast (Glandular cells, HPA High)
Negative control tissue: None in HPA: MARS1 is detected in all 45 scored tissues. Use a no-primary (secondary-only) and an isotype control instead.
ICC-IF cell lines (HPA subcellular resource): HPA ICC-IF images show MARS1 in A-431, U-251MG, U2OS, Sperm, U2OS, siRNA 1 (10x), U2OS, siRNA 2 (10x), U2OS, scrambled (10x), with annotated localisation: Cytosol (supported) (HPA subcellular).
Technical controls: Run a no-primary, secondary-only control and a concentration-matched rabbit control immunoglobulin appropriate to the primary antibody, plus a MARS1-knockout biological control where available (selected-SKU caption: rabbit primary and HRP/DAB detection). Block endogenous peroxidase and check for residual DAB background in the breast section (selected-SKU caption: HRP/DAB detection).
⚠️Feasibility: A target-specific fixation window or fixation effect is unreported, and the selected-SKU paraffin-section caption does not state the fixative (selected-SKU caption: fixative unreported). The caption documents heat retrieval in EDTA at pH 8.0, but does not establish that retrieval is required under other conditions (selected-SKU caption: EDTA retrieval). Paraffin-section IHC has a documented example; the supplied evidence does not establish that frozen sections or IF are easier, and endogenous peroxidase can create DAB background (selected-SKU caption: paraffin-section HRP/DAB IHC; HPA: ICC-IF cytosolic localization).
HPA tissue IHC evidence for MARS1
Comprehensive Human Protein Atlas IHC scoring per tissue (reliability: Supported — Medium consistency between antibody staining and RNA expression data.). Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
Positive expression · recommended positive controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Breast | Glandular cells | High | Protein (IHC) | HPA → |
| Bronchus | Respiratory epithelial cells | High | Protein (IHC) | HPA → |
| Cerebellum | Synaptic glomeruli - core | High | Protein (IHC) | HPA → |
| Cerebral cortex | Neuronal cells | High | Protein (IHC) | HPA → |
| Colon | Glandular cells | High | Protein (IHC) | HPA → |
Undetected expression · recommended negative controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| None in HPA: MARS1 is detected in all 45 scored tissues. Use a no-primary (secondary-only) and an isotype control instead. | ||||
Section 3
Advanced MARS1 IHC Tips
Troubleshoot MARS1 staining in paraffin sections by checking retrieval, staining conditions and cellular distribution against the reported IHC evidence.
What retrieval should I use when MARS1 staining is weak in paraffin sections?
Start with heat-mediated retrieval in EDTA at pH 8.0 for paraffin sections (datasheet A00216-1). The selected tissue image used this retrieval before staining with 2 μg/mL primary antibody overnight at 4°C (datasheet A00216-1). If staining is weak, compare a small range of heating and cooling durations on adjacent sections while keeping the buffer, antibody concentration and detection steps constant (standard IHC practice). Judge improvement by clearer cellular staining with a clean negative control, since excessive retrieval can damage tissue morphology and increase background (standard IHC practice).
Could fixation explain inconsistent MARS1 staining across paraffin blocks?
Target-specific fixation sensitivity is unknown: the selected paraffin-section caption does not state a fixative (datasheet A00216-1). Record each block’s fixative and processing history, then compare sections processed together before attributing a staining difference to MARS1 abundance (standard IHC practice). Hold retrieval at EDTA pH 8.0 and the primary antibody at 2 μg/mL during the comparison so those variables cannot explain the difference (datasheet A00216-1). Compare morphology, background and cytoplasmic signal in matched cell populations, and treat any apparent fixation effect as an observation requiring validation rather than an established property of MARS1 (standard IHC practice; HPA: general cytoplasmic expression).
Should MARS1 appear in nuclei or only in the cytoplasm?
Expect predominantly cytosolic staining in tissue sections (HPA: general cytoplasmic expression; HPA: supported cytosol location). Nucleolar signal can also be plausible in proliferative cells, whereas UniProt reports its disappearance from nucleoli in quiescent cells (UniProt P56192: subcellular location). MARS1 has no transmembrane segment, so a sharp cell-surface outline alone is a poor match for its annotated topology (UniProt P56192: topology). When scoring DAB sections, inspect the cytoplasm and nucleoli separately at high magnification, compare neighboring cells with similar morphology, and check a negative control before calling a predominantly nuclear or peripheral pattern specific (standard IHC practice).
How can isoforms or epitope masking affect interpretation of MARS1 IHC?
MARS1 has 2 annotated isoforms, but the supplied caption does not identify this antibody’s epitope or establish which isoforms it recognizes (UniProt P56192: isoforms; datasheet A00216-1). The annotated protein includes a GST C-terminal domain at residues 74–198 and a WHEP-TRS domain at 841–897, with reported phosphorylation at 825 and 835 (UniProt P56192: domains and modified residues). Without an epitope map, do not assign weak staining to a particular isoform, domain or modification (standard IHC interpretation). Compare staining across matched sections using the documented EDTA pH 8.0 retrieval, and seek independent specificity evidence before making an isoform-specific claim (datasheet A00216-1; standard IHC practice).
How should I adapt the MARS1 localisation check for multiplex IF?
In a separate IF experiment, pair MARS1 with a marker that identifies the expected cell population, such as a glandular-cell marker when examining colon glandular cells, where tissue IHC reports high MARS1 staining (HPA: high in colon glandular cells). Choose a fluorophore in a channel with low tissue autofluorescence, and inspect unstained tissue and single-color controls before interpreting overlap (standard IF practice). Because MARS1 is mainly cytosolic and lacks a transmembrane segment, use permeabilisation appropriate for an intracellular epitope and titrate it against cell preservation (HPA: supported cytosol location; UniProt P56192: topology; standard IF practice). Assess any nucleolar signal in the context of proliferation, since UniProt reports nucleolar localisation in proliferative cells (UniProt P56192: subcellular location).
How do I distinguish weak MARS1 staining from DAB background?
Compare the stained section with a matched section lacking primary antibody to identify signal produced by detection reagents or endogenous tissue activity (standard IHC practice). Include a peroxidase-blocking step before HRP and DAB development, and inspect pigment and tissue folds under brightfield illumination (standard chromogenic IHC practice). The selected image used 10% goat-serum blocking, 2 μg/mL primary antibody overnight at 4°C, and DAB-based detection (datasheet A00216-1). If diffuse color obscures cells, titrate the primary antibody and development time one at a time, looking for reproducible cytoplasmic staining consistent with the tissue profile (standard IHC practice; HPA: general cytoplasmic expression).
What should I score when comparing MARS1 across paraffin sections? ⚠ ANSWER MARKED FOR VERIFICATION
Define the cell population and tissue area before scoring, since HPA reports high staining in several distinct populations, including breast glandular cells and bronchial respiratory epithelial cells (HPA: tissue IHC). Within the same population, report an H-score from staining intensity and percentage of positive cells, or report the percentage positive using a prespecified threshold (standard IHC scoring practice). If measuring positive-cell density per mm², normalize to viable tissue area and report the number of evaluable cells or regions (standard IHC scoring practice). Keep retrieval, DAB development, imaging and threshold settings consistent across sections, and score cytoplasmic and nucleolar staining separately when both are present (datasheet A00216-1; UniProt P56192: subcellular location; standard IHC practice).
Which staining patterns would make a MARS1-positive call doubtful?
A convincing call should show cellular staining compatible with the predominantly cytosolic profile, with possible nucleolar staining in proliferative cells (HPA: general cytoplasmic expression; UniProt P56192: subcellular location). Isolated membrane rims are suspect because MARS1 has no transmembrane segment, while signal confined to an unexpected cell population needs separate validation (UniProt P56192: topology; standard IHC interpretation). Inspect section edges, folds and necrotic areas for uneven DAB deposition, and use a no-primary control to check endogenous enzyme or detection background (standard chromogenic IHC practice). Treat the selected prostate-cancer paraffin image as evidence of staining under its stated conditions, rather than proof that every stained structure or cell is MARS1-specific (datasheet A00216-1; standard IHC interpretation).
Boster reagents
Best MARS1 / Methionine--tRNA ligase, cytoplasmic IHC Antibodies
A00216-1 has IHC data from human paraffin-embedded prostate and thyroid cancer sections and IF data from U2OS cells and human prostate cancer sections (catalog image captions).
Real IHC data
Anti-MARS1 Antibody ®
Cat # A00216-1
A00216-1 is listed for human IHC and IF/ICC (catalog: applications and reactivity). Its captions show IHC in paraffin-embedded human prostate and thyroid cancer sections, plus IF in U2OS cells and a paraffin-embedded human prostate cancer section (catalog image captions).
Which to pick: Choose A00216-1 for human paraffin-section IHC: its own captions document both tissue examples, and the listed IHC concentration is 2–5 μg/ml (catalog IHC captions; datasheet: IHC dilution). For IF/ICC, A00216-1 has documented U2OS cell IF and prostate-section IF at 5 μg/ml (catalog IF captions; datasheet: IF dilution). No cross-species option is listed because A00216-1 specifies human reactivity; its tissue captions do not report the fixative (catalog: reactivity; catalog IHC/IF captions).
Each figure is that product's own IHC / IF validation image from its datasheet.
References
- UniProt Consortium. UniProt entry P56192 (SYMC_HUMAN, Methionine--tRNA ligase, cytoplasmic).
- Human Protein Atlas. MARS1 tissue IHC expression (reliability: Supported).
- Human Protein Atlas. MARS1 subcellular location (ICC-IF): Mainly localized to the cytosol. In addition localized to the mid piece, principal piece and end piece..
- Human Protein Atlas. MARS1 antibody validation summary (2 antibodies).
- A New Staining Method Using Methionyl-tRNA Synthetase 1 Antibody for Endoscopic Ultrasound-Guided Fine-Needle Aspiration Cytology of Pancreatic Cancer. Diagnostics (Basel, Switzerland) 2025 — PMC12293401.
- Prediction of Prognosis in Pancreatic Cancer According to Methionyl-tRNA Synthetase 1 Expression as Determined by Immunohistochemical Staining. Cancers 2023 — PMC10670752.
- Methionyl-tRNA synthetase 1 expression, the possibility as a diagnostic and prognostic factor in papillary thyroid cancer. BMC cancer 2025 — PMC12676747.
- Methionyl-tRNA synthetase 1 participates in hepatocellular carcinoma and its regulated gene profile possesses potent prognostic ability. World journal of gastrointestinal oncology 2025 — PMC12624232.
- PubMed PMID:8921912 — UniProt-cited evidence.
- PubMed PMID:14702039 — UniProt-cited evidence.
- PubMed PMID:16541075 — UniProt-cited evidence.
Immunohistochemistry protocol sheet for MARS1 (Methionine--tRNA ligase, cytoplasmic). Expected localisation General cytoplasmic staining (HPA tissue IHC). Antigen retrieval: EDTA pH 8.0 HIER, heat-mediated (datasheet A00216-1). Validated IHC antibody: A00216-1 at 2-5 μg/ml (the product's own IHC validation image is shown). Controls (HPA): positive Breast (Glandular cells); negative None in HPA (detected in all 45 tissues); use no-primary + isotype controls. IHC-P workflow on paraffin sections; fixative unspecified. Protocol steps: 1. Sample: Paraffin-embedded human prostate cancer tissue; fixative not specified (datasheet A00216-1); 2. Fixation: Image fixative and duration unreported (datasheet A00216-1); verify before use.; 3. Sectioning: 4–5 µm sections on charged slides (standard); 4. Deparaffinisation: Xylene, graded ethanol series to water (standard); 5. Antigen retrieval: Heat retrieval: EDTA pH 8.0 (datasheet A00216-1); 20 min, 95–100 °C (standard); 6. Peroxidase block: 3% H2O2, 10 min , room temperature (standard); 7. Blocking: 10% goat serum (datasheet A00216-1); 8. Primary antibody: Rabbit anti-MARS1, 2-5 μg/ml (datasheet A00216-1); 9. Primary incubation: Overnight at 4 °C (datasheet A00216-1). Watch for: Fixation: Keep paraffin-section fixation consistent. (standard IHC practice; not target-specific); Caveat: Nucleolar signal can disappear in quiescent cells (UniProt); Isoform / epitope: 2 isoforms; epitope impact unknown; no TM segment (UniProt); Regulation: Nucleolar localization in proliferative cells (UniProt). Evidence: UniProt P56192, HPA tissue IHC · Supported, HPA ICC-IF · Mainly localized to the cytosol. In addition localized to the mid…, Datasheet A00216-1, PMC12293401, PMC10670752. QR code links to https://www.bosterbio.com/bosterbio-gene-info-cards/MARS1/immunohistochemistry-ihc-guide.